Abstract
A systematic review of randomized clinical trials (RCT) was undertaken to evaluate the beneficial and harmful effects of immunosuppression with cyclosporin versus tacrolimus for liver transplanted patients. MEDLINE, EMBASE, Cochrane Central and Hepato-Biliary Group Controlled Trials Registers were searched. Using fixed and random effects model, relative risk (RR), values
| Original language | English |
|---|---|
| Journal | American Journal of Transplantation |
| Volume | 6 |
| Issue number | 7 |
| Pages (from-to) | 1578-85 |
| Number of pages | 8 |
| ISSN | 1600-6135 |
| DOIs | |
| Publication status | Published - Jul 2006 |
Keywords
- Acute Disease
- Cyclosporine
- Follow-Up Studies
- Graft Rejection
- Humans
- Immunosuppressive Agents
- Liver Transplantation
- Risk Factors
- Tacrolimus
Fingerprint
Dive into the research topics of 'Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS